Biotech Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Week


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Age-Related Macular Degeneration

Verteporfin enhanced feeder vessel therapy may improve subfoveal choroidal neovascularization

Researchers in the United States conducted a study "to investigate the safety and effectiveness of extrafoveal photodynamic therapy (PDT) occlusion of FVs in patients with subfoveal CNV as a result of age related macular degeneration. FVs were identified using dynamic fluorescein and indocyanine green angiography with scanning laser ophthalmoscope. The standard doses of verteporfin and laser wavelength were used."

"The light dose was escalated by increasing the duration of the light dose so the light regimen was 50 J/cm² for patients 1...

• View Other Issues of Biotech Week
  
• View Other NewsRx Publications